NL-OMON47065已完成4 期
Mechanism of action study of Ustekinumab treatment in psoriatic arthritis: Impact on cellular and molecular pathways of synovial inflammation and tissue remodeling - MoA-Ustekinumab
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Psoriatic artrhritis according to the CASPAR criteria
- •Active disease defined as SJC/TJC of 3 or more
- •Presence of knee and/or ankle arthritis in order to get synovial tissue biopsies
- •Is going to receive ustekinumab treatment for his/her psoriatic artrhitis
排除标准
- •- Previous use of ustekinumab, il17blocking therapy or multiple TNF blocking therapy use
- •- Contra-indication for needle arthroscopy such as joint replacement surgery and anti-coagulation use (that can not be temporarily stopped)
研究者
相似试验
进行中（未招募）
不适用
Mechanism of action study of Ustekinumab treatment in psoriatic arthritispsoriatic arthritisMedDRA version: 17.1Level: LLTClassification code 10066579Term: Progression of psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10066730Term: Recurrent psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10003377Term: Arthropathy psoriaticSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10037161Term: Psoriatic arthritis aggravatedSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: PTClassification code 10037162Term: Psoriatic arthropathySystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: HLTClassification code 10037163Term: Psoriatic arthropathiesSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10037166Term: Psoriatic spondylitisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2014-003148-11-NLAcademic Medical Center
Unknown
不适用
Mechanism of Action of Ustekinumab in Psoriatic ArthritisArthritis, PsoriaticNCT03565042Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)16
已完成
不适用
Effectiveness of Ustekinumab in Induction and Maintenance Therapy of ulcerative colitis (RUN-UC)K51Ulcerative colitisDRKS00022043CED Service GmbH507
招募中
不适用
Prospective evaluation of ustekinumab(UST)- effects in patients with ulcerative colitisulcerative colitisJPRN-UMIN000039946Saitama Medical Ctnter, Saitama Medical University35
招募中
4 期
Prospective follow-up study of ustekinumab treatment in psoriatic arthritisrheumatic disease10023213psoriatic arthritisNL-OMON40967Jan van Breemen Instituut50